Please login to the form below

Not currently logged in
Email:
Password:

Crescendo Biologics appoints Edward Stewart as chief business officer

He joins the Cambridge, UK-based firm from Merrimack Pharmaceuticals

Biopharmaceutical group Crescendo Biologics has appointed Edward Stewart as its new chief business officer.

Stewart joins the Cambridge, UK-based firm from Merrimack Pharmaceuticals, where he served in several executive roles, including leading the commercial business unit and the business development function.

He said: “Crescendo is developing very exciting and highly differentiated pipeline of therapeutics.

“I look forward to joining the team and contributing my experience to advance those products, achieve our corporate goals and realise the full potential of the Humabody platform.”

Stewart has over 20 years’ of experience working in the biotechnology field and his expertise lies in growing pre-clinical organisations to commercial enterprises and market launches.

Peter Pack, CEO of Crescendo Biologics, said: “A strong and experienced team is key to reaching our ambitions and Stewart brings broad experience in business and corporate development as well as organisational growth, making him a great addition to our leadership team.”

20th June 2017

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Videum Health

Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...

Latest intelligence

Robust Review: COVID19 Assessment
See how our client utilized Rapid Payer Response (RPR) to stay informed and gain continuous insights during the recent global pandemic (COVID19)...
Human behaviour - Sept 21
All change – how untangling human behaviour can encourage better health
Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...